Latest Breaking News On - கிறிஸ் சுற்று - Page 1 : comparemela.com

Chutes & Ladders—Another Novartis exec answers the biotech call, this time for gene therapy startup Tevard

Novartis has lost another NIBR exec to the call of biotech. Blueprint Medicines has added another BMS vet to its roster. And Iovance quietly announced its CEO's departure Wednesday.

United statesStephen bassoInozyme pharmaFraiser kansteinerEli lillyMann muhsinEverett croslandBradley gloverGopi shankerGary romanoGary baldwinRichard morrisSugandh sharmaTyler ralstonJohnson janssenAeglea biotherapeutics

Merck KGaA, Darmstadt, Germany, Announces Changes in Operating Model for Healthcare Business Sector

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced changes in its operating model for the Healthcare business sector. Chris Round will become President of EMD Serono leading the North America Healthcare business; Andrew Paterson will assume the position of Chief Marketing Officer; and recruitment is ongoing for the position of Head of China & International. “Our redesigned Healthcare organization creates dedicated leadership for our strategic priorities with a focus on growth,” said Peter Guenter, Member of the Executive Board of Merck KGaA, Darmstadt, Germany, and CEO Healthcare. “Our clear intent is to bring meaningful value to more patients with our current and future portfolio.”

United statesMerck kgaPeter guenterAndrew patersonHead of china internationalHead of internationalGroup websiteMerck co incMerck kgaaNorth america healthcareChief marketing officerExecutive boardNorth americaChris roundCanada healthcareCore franchises

Merck KGaA s new CEO shakes up U S leadership to spark sales of promising drugs

May 18, 2021 11:39am Germany-based Merck KGaA saw an 8.6% increase in sales in 2020 and looks for even more success with reorganization of its healthcare unit in North America as it tries to spur sales of Mavenclad, Bavencio and Tepmetko. (Fierce Pharma) Belen Garijo took over last month as CEO at Merck KGaA and she’s not wasting time putting her imprint on the company. On Tuesday, the Germany-based company said it had tapped Chris Round as president at its North America healthcare unit, replacing Andrew Patterson, who ll step into the brand-new role of chief marketing officer. By beefing up its leadership in the United States, Merck aims to help EMD Serono cash in with three promising drugs––its Pfizer-partnered immuno-oncology drug Bavencio, multiple sclerosis treatment Mavenclad and Tepmetko for non-small cell lung cancer.

United statesMatthias heinzelStefan oschmannNovarti tabrectaBristol myers squibb opdivoBelen garijoPeter guenterAndrew pattersonMerck kgaMerck kgaaMerck coChris roundNorth americaMillipore sigmaMiddle eastBristol myers squibb

K&L Gates expands IP scope with launch of new trademarks agency

K&L Gates expands IP scope with launch of new trademarks agency
lawyersweekly.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lawyersweekly.com.au Daily Mail and Mail on Sunday newspapers.

Hong kongUnited kingdomEmma ryanEdward yaoChina national intellectual property administrationKl gates ip agencyChris roundஹாங் காங்ஒன்றுபட்டது கிஂக்டம்எம்மா ரியான்எட்வர்ட் யாவ்கிறிஸ் சுற்று